If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
318.60    -7.80 (-2.39%)
Bid:
317.20
Ask:
318.60
Spread: 1.40 (0.441%)
Market Cap: £697.95m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

Burford Appoints Mark Klein as General Counsel

12 Sep 2017 09:00

RNS Number : 4697Q
Burford Capital
12 September 2017
 

 

Burford Capital Appoints Mark Klein as General Counsel

September 12, 2017 - Burford Capital ("Burford"), a leading global finance firm focused on law, has appointed Mark Klein as its General Counsel, effective immediately. Mr. Klein will be based in Burford's New York office.

A graduate of New York University School of Law, Mr. Klein has extensive experience providing in-house legal expertise in the financial services industry, working with companies from a global banking giant to a US registered investment advisor.

Mr. Klein spent 13 years at UBS in a wide range of corporate roles. From 2008 to 2013, after holding a variety of other in-house roles at UBS from 2000 to 2008, he was Managing Director and General Counsel of Infrastructure & Private Equity, where he worked on all aspects of the business, from structuring and marketing regulated funds through to executing the acquisitions on behalf of those funds. Most recently, he was General Counsel and Chief Compliance Officer at Marketfield Asset Management, a large US registered investment adviser.

He began his career in private practice at Weil, Gotshal & Manges LLP, where he worked on public and private mergers and acquisitions, debt and equity capital markets and securities law, among other areas.

Christopher Bogart, Burford's CEO, commented: "Burford's team is unmatched in combining legal insight and financial savvy, understanding of the business of law and ambition to innovate its economics. Mark is a great fit for our culture and adds a wealth of experience that will be highly relevant as Burford continues to grow as a business and to develop new solutions for our clients."

END

Contact:

UK/Europe: Neil McLeod, PHA Media, 020 7440 0811, neilm@pha-media.com

US: Emma Murphy, The Neibart Group, (718) 875 4545, emurphy@neibartgroup.com 

 

About Burford Capital

Burford Capital is a leading global finance and investment management firm focused on law. Its businesses include litigation finance and risk management, asset recovery, and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London and Chicago. For more information about Burford: www.burfordcapital.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUUUBRBNAKARR
Date   Source Headline
2nd Jul 202611:00 amRNSIssue of Equity in Connection with LTIP
25th Jun 202611:00 amRNSIssue of Equity in Connection with NED Plan Grants
17th Jun 202612:00 pmRNSDirector/PDMR Shareholding & Equity Issue re DCP
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.